Here’s Chamath Palihapitiya's investment argument for his Clover SPAC
October 06, 2020 at 10:52 AM EDT
Palihapitiya broke down his investment thesis in Clover, a seven-year-old company that sells Medicare Advantage in the U.S.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|